Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Medicure (MCUJF) Income from Continuing Operations (2016 - 2025)

Medicure has reported Income from Continuing Operations over the past 17 years, most recently at 3026821.2 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations fell 1250.89% year-over-year to 3026821.2; the TTM value through Dec 2025 reached 4863889.41, down 1181.76%, while the annual FY2025 figure was 5089161.35, 584.24% down from the prior year.
  • Income from Continuing Operations for Q4 2025 was 3026821.2 at Medicure, down from 922826.45 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 1468465.09 in Q4 2021 and troughed at 3026821.2 in Q4 2025.
  • A 5-year average of 208117.83 and a median of 83312.07 in 2023 define the central range for Income from Continuing Operations.
  • Biggest five-year swings in Income from Continuing Operations: skyrocketed 3284.04% in 2021 and later crashed 1250.89% in 2025.
  • Year by year, Income from Continuing Operations stood at 1468465.09 in 2021, then tumbled by 77.22% to 334463.13 in 2022, then tumbled by 457.97% to 1197292.91 in 2023, then soared by 81.29% to 224060.78 in 2024, then crashed by 1250.89% to 3026821.2 in 2025.
  • Business Quant data shows Income from Continuing Operations for MCUJF at 3026821.2 in Q4 2025, 922826.45 in Q3 2025, and 483547.37 in Q2 2025.